Multi-omics analyses reveal significant differences in the gut microbiota and metabolites in children with Kawasaki disease in Northwest China - Report - MDSpire
Advertisement
Multi-omics analyses reveal significant differences in the gut microbiota and metabolites in children with Kawasaki disease in Northwest China
Clinical Report: Distinct Gut Microbiota and Metabolite Variations in Kawasaki Disease
Overview
This study identifies significant alterations in gut microbiota and metabolite profiles in children with Kawasaki disease (KD) compared to healthy controls. Key findings include reduced microbial diversity and specific pathogenic species enrichment in KD patients, alongside notable metabolic pathway differences.
Background
Kawasaki disease is a systemic vasculitis that primarily affects children and can lead to serious cardiovascular complications if untreated. Understanding the gut microbiota's role in KD may provide insights into its pathogenesis and potential therapeutic targets. This study contributes to the growing body of evidence linking gut health with immune-mediated diseases in pediatric populations.
Data Highlights
Finding
Details
Alpha Diversity
Significantly reduced in KD patients
Pathogenic Species
Increased Enterococcus avium, Streptococcus peroris, Clostridioides difficile in KD
Beneficial Species
Decreased Faecalibacterium prausnitzii, Akkermansia muciniphila in KD
Metabolic Pathways
49 pathways differentially enriched; 22 abundant in KD
Fecal Metabolites
Elevated indole, L-tryptophan in KD
Plasma Metabolites
Increased cholesterol, bile acids in KD
Key Findings
Significant reductions in alpha diversity and microbial richness in KD patients.
Pathogenic species such as Enterococcus avium and Clostridioides difficile were more abundant in KD.
Beneficial gut species like Faecalibacterium prausnitzii were markedly decreased in KD.
A total of 49 metabolic pathways showed differential enrichment between KD and healthy controls.
Fecal and plasma metabolomes exhibited significant alterations in KD patients.
Clinical Implications
The findings suggest that gut microbiota profiling may serve as a potential biomarker for Kawasaki disease and highlight the importance of gut health in managing KD. Clinicians should consider the implications of microbiota and metabolite alterations in the context of KD treatment and monitoring.
Conclusion
This comprehensive multi-omics study enhances the understanding of Kawasaki disease by elucidating the distinct gut microbiota and metabolite variations in affected children. These insights may inform future therapeutic strategies and research directions.
